These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 1634610)
1. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr. Koopman J; Haverkate F; Lord ST; Grimbergen J; Mannucci PM J Clin Invest; 1992 Jul; 90(1):238-44. PubMed ID: 1634610 [TBL] [Abstract][Full Text] [Related]
2. Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia. Koopman J; Haverkate F; Grimbergen J; Lord ST; Mosesson MW; DiOrio JP; Siebenlist KS; Legrand C; Soria J; Soria C J Clin Invest; 1993 Apr; 91(4):1637-43. PubMed ID: 8473507 [TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA). Koopman J; Haverkate F; Grimbergen J; Egbring R; Lord ST Blood; 1992 Oct; 80(8):1972-9. PubMed ID: 1391954 [TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a". Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644 [TBL] [Abstract][Full Text] [Related]
5. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions. Soya K; Terasawa F; Okumura N Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100 [TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis. Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen naples I (B beta A68T) nonsubstrate thrombin-binding capacities. Meh DA; Mosesson MW; Siebenlist KR; Simpson-Haidaris PJ; Brennan SO; DiOrio JP; Thompson K; Di Minno G Thromb Res; 2001 Jul; 103(1):63-73. PubMed ID: 11434947 [TBL] [Abstract][Full Text] [Related]
8. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide. Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization. Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648 [TBL] [Abstract][Full Text] [Related]
10. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization. Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451 [TBL] [Abstract][Full Text] [Related]
12. Unusual A alpha 16Arg-->Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings. Galanakis D; Spitzer S; Scharrer I Blood Coagul Fibrinolysis; 1993 Feb; 4(1):67-71. PubMed ID: 8457654 [TBL] [Abstract][Full Text] [Related]
13. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin. Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658 [TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro). Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644 [TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis. Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699 [TBL] [Abstract][Full Text] [Related]
17. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions. Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918 [TBL] [Abstract][Full Text] [Related]
18. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine. Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836 [TBL] [Abstract][Full Text] [Related]